Note 17 - Fair Value Disclosures (Tables)

9 Months Ended

Sep. 30, 2018

Notes Tables

Fair Value, by Balance Sheet Grouping [Table Text Block]

	Fair Value Measured at Reporting Date Using
	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At September 30, 2018:
Cash and cash equivalents	$	170,219	$	-	$	170,219	$	-	$	170,219
Other receivables	$	463,906	$	-	$	-	$	463,906	$	463,906
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC – related party	$	875,328	$	-	$	-	$	875,328	$	875,328
Loans payable	$	10,122,412	$	-	$	-	$	10,122,412	$	10,122,412
Loans payable – related parties	$	1,362,727	$	-	$	-	$	-	$	-
Convertible notes payable	$	4,848,460	$	-	$	-	$	5,178,663	$	5,178,663
Convertible notes payable – related parties	$	2,710,313	$	-	$	-	$	-	$	-

	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At December 31, 2017:
Cash and cash equivalents	$	84,978	$	-	$	84,978	$	-	$	84,978
Other receivables	$	222,562	$	-	$	-	$	222,562	$	222,562
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC – related party	$	775,328	$	-	$	-	$	775,328	$	775,328
Loans payable	$	9,981,883	$	-	$	-	$	9,981,883	$	9,981,883
Loans payable – related parties	$	1,138,923	$	-	$	-	$	-	$	-
Convertible notes payable	$	3,670,172	$	-	$	-	$	3,831,760	$	3,831,760
Convertible notes payable – related parties	$	2,710,313	$	-	$	-	$	-	$	-